PATH-27. MUTATION DETECTION USING PLASMA CELL-FREE DNA IN CHILDREN WITH CENTRAL NERVOUS SYSTEM TUMORS

BACKGROUND: The role of plasma cell-free DNA (cfDNA) as a cancer biomarker for tracking treatment response and detecting early relapse has been well described for solid tumors outside the central nervous system (CNS). However, the presence of a blood-brain barrier complicates the application of plas...

Descripción completa

Detalles Bibliográficos
Autores principales: Mangum, Ross, Reuther, Jacquelyn, Baksi, Koel Sen, Zabriskie, Ryan C, Gandhi, Ilavarasi, Recinos, Alva, Potter, Samara L, Lin, Frank Y, Chintagumpala, Murali, Muzny, Donna M, Fisher, Kevin, Plon, Sharon E, Roy, Angshumoy, Parsons, D Williams
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Pathology and Molecular Diagnosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715949/
http://dx.doi.org/10.1093/neuonc/noaa222.662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715949/
http://dx.doi.org/10.1093/neuonc/noaa222.662

Ejemplares similares